Drugs and Diagnostics for Hematological Disorders: Global Markets

Sep 2016| PHM116B| BCC Publishing
Ask a Question

Report Highlights

The global market for hematology drugs and diagnostics is expected to grow from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a compound annual growth rate of 7.5% from 2015-2020.

Report Includes

  • An overview of the global market for drugs and diagnostics for hematological disorders.
  • Analyses of global market trends, with data from2015, and projections of CAGRs through 2020.
  • A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics.
  • A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies.
  • Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities
  • Delineation of drugs approved by the FDA for hematological disorders.
  • Profiles of key companies in the industry.

SCOPE OF THE STUDY

The scope of this study covers instruments, reagents, testing, screening technology and the therapeutics markets for hematological disorders, including hemophilia and blood cancers. The report also discusses the regulatory environment, current technologies, new technologies, hematological disorders and cancer incidence, market projections and market share, along with latest trends, and clinical and new developments.

ANALYST’S CREDENTIALS

Usha Nagavarapu is an experienced pharmaceutical professional with scientific and business development experience. She has managed preclinical discovery programs from target identification, including IND enabling studies, and assisted out-licensing and portfolio development activities. Her strong focus areas include oncology, dermatology and cardiovascular diseases. She has extensive experience working with early startups to fulfill operational obligations while minimizing overall operational cost and burden.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price Member Price
Full Report: Drugs and Diagnostics for Hematological Disorders: Global Markets 504 $2,750 Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3$250Free
Chapter- 3: HEMATALOGICAL DISORDERS56$306Free
Chapter- 4: HEMATOLOGICAL CANCERS14$76Free
Chapter- 5: LEUKEMIA27$147Free
Chapter- 6: LYMPHOMA15$82Free
Chapter- 7: MULTIPLE MYELOMA19$104Free
Chapter- 8: MYELODYSPLASTIC SYNDROMES14$76Free
Chapter- 9: MYELOPROLIFERATIVE DISORDERS35$191Free
Chapter- 10: EPIDEMIOLOGY OF HEMATOLOGICAL CANCERS83$453Free
Chapter- 11: HEMATOLOGY INSTRUMENTS AND REAGENTS: A GLOBAL MARKET PERSPECTIVE33$180Free
Chapter- 12: GLOBAL MARKET FOR TREATMENTS FOR HEMATOLOGICAL DISORDERS71$387Free
Chapter- 13: HEMATOLOGICAL CANCER THERAPIES MARKET86$469Free
Chapter- 14: PATENT LANDSCAPE AND CURRENT DEVELOPMENTS16$87Free
Chapter- 15: SELECTED COMPANY PROFILES21$115Free
Chapter- 16: BIBLIOGRAPHY7$38Free
Published - Mar-2013| Analyst - Usha Nagavarapu| Code - PHM116A

Report Highlights

The total global market for hematological disorder drugs and diagnostics in 2012 was estimated at nearly $72.9 billion. By 2017, the market is expected to reach $99.1 billion, growing at a compound annual growth rate (CAGR) of 6.4% between 2012 and 2017.

Report Includes

  • An overview of the global market for drugs and diagnostics for hematological disorders.
  • Analyses of global market trends, with data from 2010 through 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics.
  • A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies.
  • Delineation of drugs approved by the FDA for hematological disorders.
  • Comprehensive profiles of key companies in the industry.

When do I get the report?
Most reports are fulfilled immediately. In some cases, it could take up to 24 hours.

In what format does this report get delivered to me?
We will send you an email with login credentials to access the report. You will also be able to download the pdf.

What are the free reports included in my purchase?
They consist of a collection of current reports from various partner publishers scanning multiple industries.

What is the difference between BCC Research and BCC Publishing?
BCC Research curates thousands of reports from different sources and provides access to this content to our clients. BCC Publishing is the publication arm of BCC Research (one of several publishers in our portal).

What reports do I get 'discounts' on with my purchase?
All reports. BCC Publishing reports will be available for a 50% discount. All other partner publishers are also available at deeply discounted rates.

Where are you located?
Wellesley Massachusetts, just outside of Boston, Massachusetts, USA.

How long has BCC Research been around?
We are approaching our 50 year anniversary in 2021!

What if I want you to invoice me for payment via Purchase Order?
Simply choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

What if I have a question about your reports?
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times, and included in every purchase, to help our customers find the research they need-when they need it.

Can I share this report with my team?
Absolutely yes, with the purchase of additional user licenses.

Can I use your research in my presentation?
Absolutely yes, so long as the publisher is properly cited.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report